← Leaderboards
Chandramohan Wakade
Charlie Norwood Va Medical Center
$0
Attributed
$0
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $0 · FY2016–22$1$1$1$0$0
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
VA$0 · 2
By mechanism
I01$0 · 2
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Oxidative Stress”
- Leonardo Trasande · New York University School Of Medicine$57,471,048
- Rosalind J Wright · Icahn School Of Medicine At Mount Sinai$36,739,005
- Claire Gmachl · Princeton University$34,397,540
- Akram N Alshawabkeh · Northeastern University$31,872,089
- Gervasio A Lamas · Mount Sinai Medical Center (Miami Beach)$31,629,832
- Robert O Wright · Brigham And Women'S Hospital$30,479,869
Research focus
Oxidative StressSubstantia Nigra StructureMotor SymptomNicotinic AcidsReportingReceptor Up-RegulationMacrophageMotorNeuroinflammationNiacinamidePharmaceutical PreparationsPathologyReceptorCellsInflammationLeukocytesDopamineMitochondriaCognitive FunctionCarbidopaNeurologicCostParkinson DiseaseSupplementation
Grant awards (10)
NAPS: Niacin for Parkinson's Disease$0
I01 · FY2022 · VA · contact PI
NAPS: Niacin for Parkinson's Disease$0
I01 · FY2021 · VA · contact PI
NAPS: Niacin for Parkinson's Disease$0
I01 · FY2021 · VA · contact PI
GPR109A and Parkinson's Disease: Role of Niacin in Outcome Measures$0
I01 · FY2020 · VA · contact PI
GPR109A and Parkinson's Disease: Role of Niacin in Outcome Measures$0
I01 · FY2020 · VA · contact PI
GPR109A and Parkinson's Disease: Role of Niacin in Outcome Measures$0
I01 · FY2020 · VA · contact PI
NAPS: Niacin for Parkinson's Disease$0
I01 · FY2019 · VA · contact PI
GPR109A and Parkinson's Disease: Role of Niacin in Outcome Measures$0
I01 · FY2018 · VA · contact PI
GPR109A and Parkinson's Disease: Role of Niacin in Outcome Measures$0
I01 · FY2017 · VA · contact PI
GPR109A and Parkinson's Disease: Role of Niacin in Outcome Measures$0
I01 · FY2016 · VA · contact PI